Thomas Wadden

50PUBLICATIONS
104CO-AUTHORS
PharmacogenomicsSocial and personality psychology not elsewhere classifiedFood properties (incl. characteristics and health benefits)Behavioural epidemiologySocial determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Mar 31, 2026
Use of Naltrexone-Bupropion in Persons With Overweight/Obesity and Symptoms of Depression: A Pooled Analysis.

Jena Shaw Tronieri, Robert F Kushner, Caroline M Apovian

|Jan 15, 2026
Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.

Thomas A Wadden, Maria A Oquendo, Robert F Kushner

|Nov 17, 2025
Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide.

Wonkyung Choi, Young-Hoon Nho, Liming Qiu

|Sep 16, 2025
Quality of life improvements associated with weight loss using a novel shape-shifting hydrogel capsule: RESET study results.

Robert F Kushner, Jamy D Ard, Thomas A Wadden

|Mar 07, 2025
Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial.

Jena S Tronieri, Eleanor Ghanbari, Jonathan Chevinsky

Pageof 9